Advertisement

Topics

Catalyst Pharmaceutical Partners Company Profile

04:50 EDT 19th June 2018 | BioPortfolio

Catalyst is a specialty pharmaceutical company of Coral Gables, Florida, that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction. Catalyst is developing vigabatrin (designated CPP-109 by Catalyst) for the treatment of addiction to cocaine, methamphetamine and other addictive substances. The National Institute on Drug Abuse has stated that finding a pharmacological treatment for cocaine addiction is their number one research priority.The U.S. Food and Drug Administration has recognized that cocaine addiction is a "serious, life-threatening condition for which there is no current drug treatment," and the National Institute on Drug Abuse (NIDA) has stated that finding a pharmacological treatment for cocaine addiction is their number one research priority. Because of the high social and financial cost of addiction, Catalyst's mission to develop a treatment for drug addiction could prove beneficial not only to addicts, but to investors and to society at large. Catalyst is particularly interested in vigabatrin as the result of two proof-of-concept studies in humans and a number of successful animal trials. Previous studies in established animal models of addiction, involving both rats and primates, have shown that vigabatrin interrupts the neural mechanisms essential for addiction. In preclinical studies, vigabatrin prevented the characteristic drug-seeking behavior of addicted animals.

Location

220 Miracle Mile, Suite 234
Coral Gables
FL
33134
United States of America

Contact

Phone: (305) 529-2522
Fax: (305) 529-0933


News Articles [897 Associated News Articles listed on BioPortfolio]

Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q1 2018 Results - Earnings Call Transcript

Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q4 2017 Results - Earnings Call Transcript

A simple catalyst helps to assemble complex molecular frameworks of antifungal agents

(AKSON Russian Science Communication Association) A team of Russian chemists led by Professor Dmitry Perekalin from Nesmeyanov Institute of Organoelement Compounds have recently developed a new rhodiu...

Catalyst Pharmaceutical (CPRX) Presents At BIO CEO & Investor Conference - Slideshow

Highly efficient ammonia synthesis catalyst developed

Researchers have discovered that a catalyst of calcium amide with a small amount of added barium (Ba-Ca(NH2)2) with ruthenium nanoparticles immobilized onto it can synthesize ammonia at an efficiency ...

Umicore to Buy Materia’s Metathesis Catalyst Arm

Belgian materials technology and recycling group Umicore has agreed to acquire the metathesis catalyst business of Pasadena, California-based Materia Inc., valuing the assets at $27 million. Umicore s...

Catalyst seeks FDA nod for Lambert-Eaton myasthenic syndrome therapy

Catalyst Pharmaceuticals filed a new drug application with the FDA seeking approval for Firdapse, or amifampridine, which is  -More- 

Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromusc...

PubMed Articles [1131 Associated PubMed Articles listed on BioPortfolio]

Evaluating a psychosocial intervention for men with prostate cancer and their partners: Outcomes and lessons learned from a randomized controlled trial.

This study evaluated the process and outcome of a psychosocial intervention for men with prostate cancer and their partners. As more men survive prostate cancer, they and their partners need help and ...

Industrial wastewater advanced treatment via catalytic ozonation with an Fe-based catalyst.

An Fe-based catalyst was used as a heterogeneous catalyst for the ozonation of industrial wastewater, and key operational parameters (pH and catalyst dosage) were studied. The results indicated that t...

Plasma-catalyst hybrid reactor with CeO2/γ-Al2O3 for benzene decomposition with synergetic effect and nano particle by-product reduction.

A dielectric barrier discharge (DBD) catalyst hybrid reactor with CeO2/γ-Al2O3 catalyst balls was investigated for benzene decomposition at atmospheric pressure and 30 °C. At an energy density of ...

Development of a framework catalyst for photocatalytic hydrogen evolution.

The controlled self-assembly of a catalyst module composed of a Rh(ii) paddle-wheel dimer bearing 1,8-naphthalimide-based moieties afforded a novel heterogeneous framework catalyst (FC-1). The framewo...

Sinter-resistant and highly active sub- 5 nm bimetallic Au-Cu nanoparticle catalyst encapsulated in silica for high-temperature carbon monoxide oxidation.

A novel gold-copper based silica encapsulated mixed metal oxide (MMO) core-shell catalyst - with sub 5-nm MMO particles - was successfully synthesized via a reverse micelle process. The SiO2 encapsula...

Clinical Trials [592 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Companies [2243 Associated Companies listed on BioPortfolio]

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromu...

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

Catalyst Pharmaceutical Partners

Catalyst is a specialty pharmaceutical company of Coral Gables, Florida, that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction. Catalyst is d...

Catalyst Communications

Catalyst [Kat-a-list] noun: 1. a powerful agent whose action inspires substantial change and the creation of new, different entities. 2. an agent that increases the rate of change in systems. ...

More Information about "Catalyst Pharmaceutical Partners" on BioPortfolio

We have published hundreds of Catalyst Pharmaceutical Partners news stories on BioPortfolio along with dozens of Catalyst Pharmaceutical Partners Clinical Trials and PubMed Articles about Catalyst Pharmaceutical Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Pharmaceutical Partners Companies in our database. You can also find out about relevant Catalyst Pharmaceutical Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record